Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants

Owing to the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants, the development of effective and safe vaccines has become a priority. The measles virus (MeV) vaccine is an attractive vaccine platform as it has been administered to children for more than 40...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwak, Hye Won, Park, Hyo-Jung, Jung, Seo-Yeon, Oh, Eun Young, Park, Sang-In, Kim, Yeonhwa, Park, Hyeong-Jun, Park, Sohyun, Kim, You-Jin, Ko, Hae Li, Lee, Jung-Ah, Won, Hyeran, Hwang, Yun-Ho, Kim, Seo Yeon, Kim, Se Eun, Bae, Seoung Eun, Yoon, Minhyuk, Kim, Jae-Ouk, Song, Manki, Lee, Su Jeen, Seo, Ki-Weon, Lee, Kunse, Kim, Dokeun, Kim, Hun, Lee, Sang-Myeong, Hong, So-Hee, Nam, Jae-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902292/
https://www.ncbi.nlm.nih.gov/pubmed/36792434
http://dx.doi.org/10.1016/j.vaccine.2023.02.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902292/
https://www.ncbi.nlm.nih.gov/pubmed/36792434
http://dx.doi.org/10.1016/j.vaccine.2023.02.005

Ejemplares similares